Dual-temporal resolution dynamic contrast-enhanced MRI protocol for blood-brain barrier permeability measurement in enhancing multiple sclerosis lesions

Journal of Magnetic Resonance Imaging

Volumn 33, Issue 6, 2011, Pages 1291-1300

  Jelescu, I O ^a   Leppert, I R ^a   Narayanan, S ^a   Araujo D ^a,b   Arnold, D L ^a   Pike, G B ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

blood brain barrier; DCE MRI; multiple sclerosis

Indexed keywords

GADOBUTROL; GADOLINIUM PENTETATE;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DAMAGE; CASE REPORT; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; ERROR; FEMALE; HUMAN; INFLAMMATION; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERMEABILITY BARRIER; PRIORITY JOURNAL; SIMULATION;

ADULT; BLOOD-BRAIN BARRIER; BRAIN; COMPUTER SIMULATION; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; KINETICS; MAGNETIC RESONANCE IMAGING; MODELS, STATISTICAL; MULTIPLE SCLEROSIS; PERMEABILITY; TIME FACTORS;

EID: 79958259262     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22565     Document Type: Article

References (28)

1. Arnold DL, Matthews PM,. MRI in the diagnosis and management of multiple sclerosis. Neurology 2002; 58: S23-31. (Pubitemid 34411850)
2. Filippi M, Grossman RI,. MRI techniques to monitor MS evolution: the present and the future. Neurology 2002; 58: 1147-1153. (Pubitemid 34411856)
3. Larsson HBW, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB,. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990; 16: 117-131. (Pubitemid 20353802)
4. Tofts PS, Kermode AG,. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991; 17: 357-367.
5. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-232. (Pubitemid 29463104)
6. Yankeelov TE, Luci JJ, Lepage M, et al. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. Magn Reson Imaging 2005; 23: 519-529. (Pubitemid 40779238)
7. McGrath DM, Bradley DP, Tessier JL, Lacey T, Taylor CJ, Parker GJ,. Comparison of model-based arterial input functions for dynamic contrast-enhanced MRI in tumor bearing rats. Magn Reson Med 2009; 61: 1173-1184.
8. Yankeelov TE, Cron GO, Addison CL, et al. Comparison of a reference region model with direct measurement of an AIF in the analysis of DCE-MRI data. Magn Reson Med 2007; 57: 353-361. (Pubitemid 46214538)
9. Larsson HB, Courivaud F, Rostrup E, Hansen AE,. Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T(1)-weighted MRI at 3 Tesla. Magn Reson Med 2009; 62: 1270-1281.
10. Parker GJ, Roberts C, Macdonald A, et al. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 2006; 56: 993-1000. (Pubitemid 44691341)
11. Sourbron S, Ingrisch M, Siefert A, Reiser M, Herrmann K,. Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI. Magn Reson Med 2009; 62: 205-217.
12. Jelescu IO, Leppert IR, Narayanan S, Arnold DL, Pike GB,. Effects of temporal resolution on Blood-Brain Barrier permeability measurement with DCE-MRI in MS enhancing lesions. Joint Scientific Meeting of ISMRM-ESMRMB, Stockholm, Sweden; 2010.
13. Cadavid D, Wolansky LJ, Skurnick J, et al. Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study. Neurology 2009; 72: 1976-1983.
14. Filippi M, Yousry T, Campi A, et al. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS. Neurology 1996; 46: 379-378.
15. Rovaris M, Codella M, Moiola L, et al. Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses. Neurology 2002; 59: 1429-1432. (Pubitemid 35286001)
16. Sicotte NL, Voskuhl RR, Bouvier S, Klutch R, Cohen MS, Mazziotta JC,. Comparison of multiple sclerosis lesions at 1.5 and 3.0 Tesla. Invest Radiol 2003; 38: 423-427. (Pubitemid 36791336)
17. Barkhof F, Held U, Simon JH, et al. Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials. Neurology 2005; 65: 1447-1454. (Pubitemid 41552778)
18. Deoni SC, Rutt BK, Peters TM,. Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state. Magn Reson Med 2003; 49: 515-526. (Pubitemid 36262820)
19. Stanisz GJ, Henkelman RM,. Gd-DTPA relaxivity depends on macromolecular content. Magn Reson Med 2000; 44: 665-667.
20. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ,. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40: 715-724. (Pubitemid 41546838)
21. Haroon HA, Buckley DL, Patankar TA, et al. A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas. J Magn Reson Imaging 2004; 19: 527-536. (Pubitemid 38619914)
22. Li K-L, Zhu XP, Waterton J, Jackson A,. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging 2000; 12: 347-357. (Pubitemid 30612881)
23. Schabel MC, Parker DL,. Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences. Phys Med Biol 2008; 53: 2345-2373. (Pubitemid 351570916)
24. Tofts PS,. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997; 7: 91-101. (Pubitemid 28365643)
25. Horsfield MA, Morgan B,. Algorithms for calculation of kinetic parameters from T1-weighted dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2004; 20: 723-729. (Pubitemid 39313750)
26. Singh A, Rathore RK, Haris M, Verma SK, Husain N, Gupta RK,. Improved bolus arrival time and arterial input function estimation for tracer kinetic analysis in DCE-MRI. J Magn Reson Imaging 2009; 29: 166-176.
27. Vincensini D, Dedieu V, Renou JP, Otal P, Joffre F,. Measurements of extracellular volume fraction and capillary permeability in tissues using dynamic spin-lattice relaxometry: studies in rabbit muscles. Magn Reson Imaging 2003; 21: 85-93. (Pubitemid 36418726)
28. Tofts PS,. Optimal detection of blood-brain barrier defects with Gd-DTPA MRI-the influences of delayed imaging and optimised repetition time. Magn Reson Imaging 1996; 14: 373-380. (Pubitemid 26195072)